脑机接口公司何时才能有收入？马斯克的公司最新计划披露

Core Insights - Neuralink aims to achieve at least $1 billion in annual revenue by 2031, with plans to implant brain-machine interface devices in 20,000 patients each year [1][3] - The company plans to operate five large clinics within the next six years and will offer three versions of brain implant devices [1] Group 1: Product Development - Neuralink announced a roadmap for three versions of its brain-machine interface products, targeting "full-brain machine interface" integration with AI by 2028 [3] - The devices include Telepathy for communication between the brain and machines, Blindsight for vision restoration, and Deep for treating tremors and Parkinson's disease [1][3] Group 2: Clinical Trials and Revenue Projections - As of now, seven clinical trial patients have received brain implants, with five severely paralyzed patients using the device to control digital and physical devices through thought [3] - Telepathy is expected to receive regulatory approval by 2029, with plans for 2,000 surgeries per year generating $100 million in revenue; Blindsight is projected to be approved by 2030, expanding to 10,000 surgeries annually and over $500 million in revenue [3] Group 3: Financial Overview - Neuralink recently completed a funding round of approximately $600 million, bringing its valuation to around $10 billion, with total funding exceeding $1.3 billion since its inception in 2016 [3] - Notable investor Chen Tianqiao commented on the need for "patient capital" in brain-machine interface investments, highlighting the company's journey to revenue generation [3]